Iris Acquisition Corp II filed its Form 10-Q for the quarter ended September 30, 2026 with the SEC on November 6, 2026, reporting financial results for both the three and nine months ended September 30, 2026.

Key Highlights

  • Net income of $1,430,836 was reported for the three months ended September 30, 2026, compared to a net loss of $50,423 for the period from inception (July 8, 2025) through September 30, 2025.
  • Cash held in Trust Account totaled $172,550,456 as of September 30, 2026, with interest earned of $4,050,456 for the nine months ended September 30, 2026.
  • Total assets were $173,223,755 as of September 30, 2026, up from $139,598 at December 31, 2025.
  • 16,850,000 Class A ordinary shares subject to possible redemption at a redemption value of $10.24 per share as of September 30, 2026.
  • IPO consummated on February 4, 2026, with the sale of 16,850,000 Units, including 1,850,000 Units sold pursuant to partial exercise of the underwriters' over-allotment option.
  • Total shareholders' deficit was $(6,858,177) as of September 30, 2026, compared to $(43,023) at December 31, 2025.
  • Deferred underwriting fee payable of $7,115,000 was recorded as a long-term liability as of September 30, 2026.

Iris Acquisition Corp II Q3 2026 Financial Results and Trust Account Status

According to the filing, Iris Acquisition Corp II (NYSE:IRAB), a Cayman Islands-incorporated blank check company headquartered in Dubai, United Arab Emirates, reported net income of $1,430,836 for the three months ended September 30, 2026 and net income of $3,468,346 for the nine months ended September 30, 2026. The company disclosed that interest earned on cash held in its Trust Account was the primary driver of other income, contributing $1,607,506 for the three-month period and $4,050,456 for the nine-month period.

The filing disclosed that on February 4, 2026, the company completed its Initial Public Offering, selling 16,850,000 Units at a price reflected in the Trust Account balance of $172,550,456 as of September 30, 2026. The registrant reported that 133,333 Class B ordinary shares were forfeited following partial exercise of the underwriters' over-allotment option, leaving 5,616,667 Class B ordinary shares outstanding. As of November 4, 2026, there were 17,288,000 Class A ordinary shares and 5,616,667 Class B ordinary shares issued and outstanding, according to the filing.

The company reported general and administrative costs of $175,559 for the three months ended September 30, 2026 and $579,094 for the nine months ended September 30, 2026. Total current liabilities stood at $416,476 as of September 30, 2026, including accounts payable and accrued expenses of $262,641. The filing identified the company as a shell company, a smaller reporting company, and an emerging growth company.

What Was Disclosed

Iris Acquisition Corp II disclosed its unaudited condensed financial statements for the quarter ended September 30, 2026, covering its balance sheet, statements of operations, changes in shareholders' deficit, and cash flows, reflecting activity since its February 4, 2026 IPO.